The assumption that losing weight will make them more productive and more employable is also not evidence based
In SURMOUNT-5, 6.1% of Tirzepatide patients stopped treatment due to adverse events compared to 8.0% on Semaglutide
Because many state and state medicaid programs have strict rules around compounded obesity medications, compounded options are usually available only in cashpay bundles
Potential side effects include nausea, vomiting, diarrhea, and low blood sugar
Digestive Support Products: Some individuals use probiotics or digestive enzymes to support gut health, although their effectiveness can vary
Inositol may provide modest additional metabolic support, but the combination is unlikely to substantially amplify weight loss beyond what semaglutide achieves on its own